NCT03867045 - Development of a Cabozantinib (Cabometyx) Symptom Management Application for Use in Patients With Renal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 21, 2019

Primary Completion Date

December 16, 2019

Study Completion Date

December 16, 2019

Conditions

Metastatic Renal Cell Carcinoma Treated With Cabozantinib

Interventions

DEVICE

Usability of an electronic symptom management application

Usability of an electronic symptom management application in a pilot group of patients receiving cabozantinib for mRCC through data analytics and feedback from users

Trial Locations (2)

27609

Duke Raleigh Hospital, Raleigh

27710

Duke University Medical Center, Durham